MedTrace Logo

Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA)

NCT03092427 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2026-04-06

No results posted yet for this study

Summary

This study investigates the efficacy of probiotic VSL#3 as an add on standard care on the activity of the disease in patients with Juvenile Idiopathic Arthritis.

Conditions

  • Juvenile Idiopathic Arthritis

Interventions

DIETARY_SUPPLEMENT

VSL#3

Dietary Supplement

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Ulrich Meinzer, MD/PhD · APHP

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-04
Primary Completion
2021-09-04
Completion
2022-09-04

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03092427 on ClinicalTrials.gov